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Abstract
The consistent decline in critical illness mortality has a significant effect on trial design, whereby either an
improbable effect sizes or large number of patients are required.
The signal-to-noise ratio is of particular interest for the critically ill. When considering the potential signal, interventions
need to match outcomes in regard to biological plausibility. Provision of nutrition is a complex decision with many
underappreciated aspects of noise. However, a fundamental interaction is often not accounted for time.
Working as a community to evolve trial design will be our challenge for nutrition interventions in the critically ill for the
future.
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The last 10 years has seen a realisation that mortality
may not be the most meaningful outcome measure for
interventional trials in critically ill patients [1]. This is
not to say that mortality is not important, or indeed
fundamental, to our practice. However, the consistent
decline in critical illness mortality has resulted in diffi-
culty in demonstrating that an intervention is capable of
reducing mortality. This has a significant effect on trial
design, whereby to affect mortality, one needs either an
improbable effect size or a large number of patients.
In 2001, Sackett described “the only formula” of
physiological statistics (Fig. 1), whereby confidence (e.g.
the narrowness of the confidence interval around the
intervention effect expressed as absolute or relative risk
reduction) is influenced by the signal-to-noise ratio
(SNR) and the square root of the sample size [2]. The
SNR aspect of the equation is of particular interest in
randomised controlled trials (RCTs) of nutrition inter-
ventions in the critically ill as small changes in this
would require large changes in sample size to maintain
confidence.
When considering the potential signal, it would seem
appropriate to match the intervention to the outcome by
strongly considering biological plausibility—that is, how
likely it is that the intervention has the potential to influ-
ence the outcome to the expected degree [3]. In this re-
gard, the biological plausibility that small alterations in
protein/energy delivery or changes in the timing or mode
of nutrition delivery will result in detectable changes in
mortality is low. Our patients are subjected to many other
potential threats to mortality, independent of nutrition.
For this reason, discussions around more appropriate out-
comes to measure include those related to muscle mass
along with physical functional outcomes.
In their meta-analysis, Taverny et al. demonstrate that
although both physical functional outcome measures and
muscle mass are increasingly being used as primary out-
comes, mortality still dominates as the choice for many pro-
spective RCTs of nutrition in the critically ill [4].
Subsequently, they highlight the need for core-outcomes set
for nutrition trials to be developed as in other specialist
areas of critical care [5]. Aligning this with such initiatives
already being developed for trials of physical rehabilitation [6]
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would seem sensible, allowing for a future of multiple inter-
ventions using both nutrition and physical rehabilitation.
As an intervention, provision of nutrition is frequently
considered a simple therapy, but is in fact a complex
decision between dose of nutrients, timing and route, all
of which have to be decided upon based on the patient’s
unique requirements. Significant amounts of important
patient data are missing to make these decisions: accur-
ate weight and height, body composition (e.g. fat mass
vs. fat free mass), regular measurement of energy ex-
penditure and prior/usual dietary intake. This final point
is likely an important factor in determining response to
nutrition interventions, but, similar to baseline physical
function in trials of rehabilitation, is difficult to obtain.
Fundamentally, nutritional trials in critical care examine
what is delivered to the patient, not what they receive
relative to their true requirement.
The above components are, in reality, increasingly under-
stood, but underappreciated aspects of noise within nutri-
tion RCTs. The greatest contributor to noise is collectively
believed to be patient heterogeneity. In regard to nutrition
trials, this would be in terms of baseline body composition,
physical function and metabolism (which may be controlled
for with larger (squared) sample sizes). More importantly,
the response to nutrition interventions is likely to be het-
erogeneous too. Our lack of understanding of the complex-
ities of metabolism and how these change over time in
critically ill patients currently preclude appropriate trial
design and sample size calculations.
Sackett’s model of physiology as applied to RCTs was
not developed for trials in the critically ill. As such, a
fundamental interaction is missing: time. This is perhaps
where the equation fails as there is no modifier for how
long an intervention might take to result in a detectable
signal (Fig. 2). Given the median length of stay for critic-
ally ill patients is around 1 week, most nutrition inter-
ventions in RCTs are only delivered for 6–7 days which
is unlikely to result in measurable benefit. Using muscle
mass as an example to illustrate this point, changes in
muscle protein synthesis or breakdown may be seen im-
mediately after an appropriate dose of amino acids, but
for this to translate into changes in muscle mass that
can be measured by other means (e.g. muscle ultra-
sound), a much longer duration is required [7, 8].
Timing and duration of the intervention in relation to
the time point the outcome is measured is also important.
All of the above points can be highlighted using recent,
important, high-quality RCTs of nutrition interventions in
critical illness. The TARGET trial demonstrated that pro-
viding 30.2 kcal/kg/day as opposed to 21.9 kcal/kg/day had
no effect on any outcomes in any subgroup [9]. Rando-
mising 4000 patients, a number that could be considered
large enough to overcome all heterogeneity issues, may
not have overcome the fact that it is implausible for a
short intervention (median 6 days) to affect a longer term
outcome (90-day mortality). Similarly, EAT-ICU, another
well-executed RCT further highlights the importance of
considering the duration of the intervention [10]. A 7-day
(mean) nutritional intervention was unlikely to detect
6-month changes in the physical component score of the
SF-36 quality of life survey without considering post-ICU
nutrition. This last point is a pitfall of nutrition trials that
is increasingly being recognised and addressed in cur-
rently recruiting RCTs [11, 12].
Post hoc trial design critique is, of course, far easier
than performing the trials themselves. However, working
as a community to evolve trial design, integrating lessons
learnt from past trials and addressing the emerging
needs of our patients, will be our challenge for RCTs of
nutrition interventions in the critically ill for the future.
Fig. 1 Sackett’s formula of physiological statistics
Fig. 2 Signal/noise ratio as a function of time—Sackett’s modified equation
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